Format

Send to:

Choose Destination
See comment in PubMed Commons below
Rozhl Chir. 2006 Aug;85(8):381-9.

Surgical resection of colorectal liver metastases--the current standard therapy (review).

Author information

  • 1Department of General and Vascular Surgery, Johann Wolfgang Goethe-University, Frankfurt/Main, Germany. markus.golling@kgu.de

Abstract

Liver resection for colorectal metastases can be performed with curative intent in about 15-20% of patients. From a surgical point of view a radical (R0) resection is of paramount importance. Perioperative mortality is mainly linked to the extent of the liver resection (class I/II). Results of ischemic or drug induced preconditioning have been ambiguous and their clinical use is at most questionable. Five year survival following primary and repeat liver resection is consistently reported as 30-40%. Options for improvement of prognosis by purely technical means appear limited. Instead, future strategies aim at increasing the number of patients (with primarily irresectable and potentially respectable disease) amenable to curative liver resection. This could be achieved preoperatively via portal vein embolisation and neoadjuvant chemotherapy and surgically via sequential resection or a combination of surgery with local ablative therapy. All suggested modalities performed in primarily inoperable tumors should be systematically evaluated in clinical trials.

PMID:
17144119
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk